JAGUAR HEALTH, INC. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
JAGUAR HEALTH, INC. (JAGX) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $120.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2026-08-19
- JAGUAR HEALTH, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2026-06-30 was $120.00K, a 23.08% decline year-over-year.
- JAGUAR HEALTH, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2026-03-31 was $174.00K, a 8.75% increase year-over-year.
- JAGUAR HEALTH, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2025-06-30 was $156.00K.
- JAGUAR HEALTH, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2025-03-31 was $160.00K, a 37.93% increase year-over-year.
- JAGUAR HEALTH, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2025 was $608.00K, a 16.37% decline from fiscal 2024.
- JAGUAR HEALTH, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2024 was $727.00K, a 14.49% increase from fiscal 2023.
- JAGUAR HEALTH, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2023 was $635.00K, a 32.52% decline from fiscal 2022.
- JAGUAR HEALTH, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2022 was $941.00K.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month |
|---|---|---|---|---|
| 2026-06-30 | $120.00K 10-Q · filed 2026-08-19 | $294.00K 10-Q · filed 2026-08-19 | ||
| 2026-03-31 | $174.00K 10-Q · filed 2026-05-20 | |||
| 2025-12-31 | $608.00K 10-K · filed 2026-04-07 | |||
| 2025-06-30 | $156.00K 10-Q · filed 2026-08-19 | $316.00K 10-Q · filed 2026-08-19 | $593.00K derived: sum of 3 quarters · filed 2026-08-19 | $779.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $160.00K 10-Q · filed 2026-05-20 | $437.00K derived: sum of 2 quarters · filed 2026-05-20 | $623.00K derived: sum of 3 quarters · filed 2026-05-20 | |
| 2024-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $463.00K derived: sum of 2 quarters · filed 2025-11-14 | $727.00K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $186.00K 10-Q · filed 2025-11-14 | $450.00K 10-Q · filed 2025-11-14 | ||
| 2024-03-31 | $116.00K 10-Q · filed 2025-05-15 | $615.00K derived: sum of 2 quarters · filed 2025-05-15 | $751.00K derived: sum of 3 quarters · filed 2025-05-15 | $869.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $635.00K derived: sum of 2 quarters · filed 2024-11-13 | $753.00K derived: sum of 3 quarters · filed 2024-11-13 | $635.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $136.00K 10-Q · filed 2024-11-13 | $254.00K derived: sum of 2 quarters · filed 2024-11-13 | $136.00K 10-Q · filed 2023-11-14 | $905.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $118.00K 10-Q · filed 2024-08-13 | $118.00K 10-Q · filed 2023-08-14 | $769.00K derived: sum of 3 quarters · filed 2024-08-13 | $858.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.00 10-Q · filed 2024-05-14 | $651.00K derived: sum of 2 quarters · filed 2024-05-14 | $740.00K derived: sum of 3 quarters · filed 2024-05-14 | $763.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $651.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $740.00K derived: sum of 2 quarters · filed 2024-04-01 | $763.00K derived: sum of 3 quarters · filed 2024-04-01 | $941.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $89.00K 10-Q · filed 2023-11-14 | $112.00K derived: sum of 2 quarters · filed 2023-11-14 | $290.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $23.00K 10-Q · filed 2023-08-14 | $201.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $178.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |